Literature DB >> 33426065

Association of Toll-Like Receptor 4 Gene Polymorphisms with Acute Aortic Dissection in a Chinese Han Population.

Tan Li1, Xiaozheng Liu1, Hongxia Ning1, Xintong Li2, Jun Yang1, Chunyan Ma1.   

Abstract

BACKGROUND: Inflammation may be involved in the pathogenesis of acute aortic dissection (AAD). Toll-like receptor 4 (TLR4) is known to play a critical role in regulating the immune and inflammatory processes. To date, the relationship between genetic variation of TLR4 and AAD is far from clear. The purpose of our study was to illustrate the relevance of TLR4 polymorphisms with the susceptibility to AAD.
METHODS: A total of 222 AAD patients and 222 controls were enrolled in this study. Frequency distributions of TLR4 polymorphisms (rs10759932 in the promoter and rs11536889 in the 3'-untranslated region) were determined by the KASP method. Clinical parameters were acquired from subjects' medical records, and serum TLR4 levels were collected from our previously published data.
RESULTS: We found that rs10759932 polymorphism was associated with a reduced risk of AAD in the overall population (CC vs. TT: OR = 0.393, 95%CI = 0.164-0.939, P = 0.036; recessive model: OR = 0.439, 95%CI = 0.196-0.984, P = 0.045) and subgroup analyses stratified by sex. The GC genotype and dominant model of rs11536889 conferred a significantly higher risk of AAD compared with GG genotype in female subjects (GC vs. GG: OR = 3.382, 95%CI = 1.051-10.885, P = 0.041; dominant model: OR = 3.043, 95%CI = 1.041-8.900, P = 0.042). In addition, a significant interaction between the rs11536889 recessive model and dyslipidemia was observed for an increased risk of AAD (P interaction = 0.038, OR = 15.229) after the adjustment for potential clinical covariates. We also used the false-positive report probability (FPRP) analysis to validate the significant results. Furthermore, rs11536889 polymorphism could affect the maximal aortic diameters of AAD (P = 0.037), while AAD patients carrying CC genotype of rs10759932 showed lower serum TLR4 levels than TT genotype carriers (P = 0.043).
CONCLUSIONS: Our findings provide evidence for the association between TLR4 polymorphisms and AAD susceptibility in a Chinese Han population, which may have some implications for understanding the role of TLR4 in the pathophysiology of AAD.
Copyright © 2020 Tan Li et al.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33426065      PMCID: PMC7783515          DOI: 10.1155/2020/8306903

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  42 in total

Review 1.  Toll-like receptor-4 signaling pathway in aorta aging and diseases: "its double nature".

Authors:  Carmela Rita Balistreri; Giovanni Ruvolo; Domenico Lio; Rosalinda Madonna
Journal:  J Mol Cell Cardiol       Date:  2017-06-28       Impact factor: 5.000

2.  Association of Toll-like receptor 4 with hepatitis A virus infection in Assam.

Authors:  P Kashyap; M Deka; S Medhi; S Dutta; K Kashyap; N Kumari
Journal:  Acta Virol       Date:  2018       Impact factor: 1.162

Review 3.  The Roles of TLR Gene Polymorphisms in Atherosclerosis: A Systematic Review and Meta-Analysis of 35,317 Subjects.

Authors:  X Xie; X Shi; M Liu
Journal:  Scand J Immunol       Date:  2017-07       Impact factor: 3.487

4.  Association of the polymorphisms of MMP-9 and TIMP-3 genes with thoracic aortic dissection in Chinese Han population.

Authors:  Xiao-long Wang; Ou Liu; Yan-wen Qin; Hong-jia Zhang; Yi Lv
Journal:  Acta Pharmacol Sin       Date:  2014-02-03       Impact factor: 6.150

5.  Association of Toll-like receptor 4 polymorphisms with the risk of coronary artery disease in the ethnic Zhuang population of the Guangxi Province of China.

Authors:  Zhaohe Huang; Yan Liu; Limei Liang; Wenjing Liu; Suren R Sooranna; Jianjiao Mo; Li Liu; Zhile Li; Jun Guo
Journal:  Gene       Date:  2019-05-10       Impact factor: 3.688

6.  Detection of inflammation in patients with acute aortic syndrome: comparison of FDG-PET/CT imaging and serological markers of inflammation.

Authors:  H Kuehl; H Eggebrecht; T Boes; G Antoch; S Rosenbaum; S Ladd; A Bockisch; J Barkhausen; R Erbel
Journal:  Heart       Date:  2007-12-10       Impact factor: 5.994

7.  The analysis of the levels of plasma inflammation-related cytokines and endotoxins in patients with acute aortic dissection.

Authors:  Xiaojun Liu; Gang Wang; Tao Zhang
Journal:  Clin Hemorheol Microcirc       Date:  2020-02-24       Impact factor: 2.375

8.  Can the TLR-4-mediated signaling pathway be "a key inflammatory promoter for sporadic TAA"?

Authors:  Giovanni Ruvolo; Calogera Pisano; Giuseppina Candore; Domenico Lio; Cesira Palmeri; Emiliano Maresi; Carmela R Balistreri
Journal:  Mediators Inflamm       Date:  2014-07-10       Impact factor: 4.711

Review 9.  Cardiovascular Disease in Ageing: An Overview on Thoracic Aortic Aneurysm as an Emerging Inflammatory Disease.

Authors:  Calogera Pisano; Carmela Rita Balistreri; Alessandro Ricasoli; Giovanni Ruvolo
Journal:  Mediators Inflamm       Date:  2017-10-24       Impact factor: 4.711

10.  Dynamic monitoring of platelet activation and its role in post-dissection inflammation in a canine model of acute type A aortic dissection.

Authors:  Chaoyi Qin; Hongwei Zhang; Jun Gu; Zhenghua Xiao; Qin Yang; Wei Meng
Journal:  J Cardiothorac Surg       Date:  2016-05-26       Impact factor: 1.637

View more
  2 in total

1.  The association between lymphocyte-monocyte ratio and postoperative acute kidney injury in patients with acute type A aortic dissection.

Authors:  Xinwei Mu; Cui Zhang; Wenxiu Chen; Xiaochun Song; Liang Hong; Huan Xu; Yan Qian; Wenhao Zhang; Jiakui Sun; Xiao Shen; Ying Liu; Xiang Wang; Qiankun Shi; Han Liu
Journal:  J Cardiothorac Surg       Date:  2022-04-01       Impact factor: 1.637

2.  Association of NFE2L2 Gene Polymorphisms with Risk and Clinical Characteristics of Acute Type A Aortic Dissection in Han Chinese Population.

Authors:  Yiran Zhang; Qi Zheng; Ruoshi Chen; Xiaoyi Dai; Yimin Zhu; Liang Ma
Journal:  Oxid Med Cell Longev       Date:  2021-07-17       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.